129 related articles for article (PubMed ID: 20616555)
1. Neurotoxic effects of MDMA (ecstasy) on the developing rodent brain.
Dzietko M; Sifringer M; Klaus J; Endesfelder S; Brait D; Hansen HH; Bendix I; Felderhoff-Mueser U
Dev Neurosci; 2010 Aug; 32(3):197-207. PubMed ID: 20616555
[TBL] [Abstract][Full Text] [Related]
2. In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion.
Grider MH; Mamounas LA; Le W; Shine HD
J Neurosci Res; 2005 Nov; 82(3):404-12. PubMed ID: 16206279
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice.
Schulte-Herbrüggen O; Eckart S; Deicke U; Kühl A; Otten U; Danker-Hopfe H; Abramowski D; Staufenbiel M; Hellweg R
J Neurosci Res; 2008 Sep; 86(12):2774-83. PubMed ID: 18438945
[TBL] [Abstract][Full Text] [Related]
4. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
Martínez-Turrillas R; Moyano S; Del Río J; Frechilla D
Neurosci Lett; 2006 Jul; 402(1-2):126-30. PubMed ID: 16644117
[TBL] [Abstract][Full Text] [Related]
6. Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms.
Angelucci F; Ricci V; Martinotti G; Palladino I; Spalletta G; Caltagirone C; Bria P
Addict Biol; 2010 Jul; 15(3):365-7. PubMed ID: 20477754
[TBL] [Abstract][Full Text] [Related]
7. Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in Dark Agouti rat.
Adori C; Andó RD; Szekeres M; Gutknecht L; Kovács GG; Hunyady L; Lesch KP; Bagdy G
J Comp Neurol; 2011 Aug; 519(12):2353-78. PubMed ID: 21456018
[TBL] [Abstract][Full Text] [Related]
8. MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats.
Wallinga AE; ten Voorde AM; de Boer SF; Koolhaas JM; Buwalda B
Eur J Pharmacol; 2009 Sep; 618(1-3):22-7. PubMed ID: 19616536
[TBL] [Abstract][Full Text] [Related]
9. Low ambient temperature reveals distinct mechanisms for MDMA-induced serotonergic toxicity and astroglial Hsp27 heat shock response in rat brain.
Adori C; Andó RD; Balázsa T; Soti C; Vas S; Palkovits M; Kovács GG; Bagdy G
Neurochem Int; 2011 Oct; 59(5):695-705. PubMed ID: 21756954
[TBL] [Abstract][Full Text] [Related]
10. (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.
Hemmerle AM; Dickerson JW; Herring NR; Schaefer TL; Vorhees CV; Williams MT; Seroogy KB
J Comp Neurol; 2012 Aug; 520(11):2459-74. PubMed ID: 22237931
[TBL] [Abstract][Full Text] [Related]
11. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
[TBL] [Abstract][Full Text] [Related]
13. Identification of post-generation effect of 3,4-methylenedioxymethamphetamine on the mouse brain by large-scale gene expression analysis.
Eun JW; Kwack SJ; Noh JH; Jung KH; Kim JK; Bae HJ; Xie H; Ryu JC; Ahn YM; Park WS; Lee JY; Rhee GS; Nam SW
Toxicol Lett; 2010 May; 195(1):60-7. PubMed ID: 20188158
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats.
Piper BJ; Farelli JD; Meyer JS
Dev Neurosci; 2009; 31(1-2):90-4. PubMed ID: 19372690
[TBL] [Abstract][Full Text] [Related]
15. Ecstasy: are animal data consistent between species and can they translate to humans?
Easton N; Marsden CA
J Psychopharmacol; 2006 Mar; 20(2):194-210. PubMed ID: 16510478
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine.
Eun JW; Kwack SJ; Noh JH; Jung KH; Kim JK; Bae HJ; Xie H; Ryu JC; Ahn YM; Min JH; Park WS; Lee JY; Rhee GS; Nam SW
Toxicol Appl Pharmacol; 2009 May; 237(1):91-101. PubMed ID: 19285098
[TBL] [Abstract][Full Text] [Related]
17. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field.
Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
Psychopharmacology (Berl); 2002 Jan; 159(2):167-75. PubMed ID: 11862345
[TBL] [Abstract][Full Text] [Related]
18. Effects of antiepileptic drugs on mRNA levels of BDNF and NT-3 and cell neogenesis in the developing rat brain.
Shi XY; Wang JW; Cui H; Li BM; Lei GF; Sun RP
Brain Dev; 2010 Mar; 32(3):229-35. PubMed ID: 19394173
[TBL] [Abstract][Full Text] [Related]
19. Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.
Piper BJ; Meyer JS
Neurotoxicol Teratol; 2006; 28(1):95-102. PubMed ID: 16271852
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy.
Alvaro AR; Martins J; Costa AC; Fernandes E; Carvalho F; Ambrósio AF; Cavadas C
Neuroscience; 2008 Mar; 152(1):97-105. PubMed ID: 18249070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
